Aberrant LYZ expression in tumor cells serves as the potential biomarker and target for HCC and promotes tumor progression via csGRP78Zhiwen Gu, Aihua Sun, Jingnan Ye et al.|Proceedings of the National Academy of Sciences|2023Cited by 37
The coming era of proteomics-driven precision medicineYing Jiang, Fuchu He, Jian Wang et al.|National Science Review|2025Cited by 22